A Glimpse into My 2025 Stock Picks (US Edition)As we enter 2025, the U.S. stock market presents a landscape ripe with opportunities. The Federal Reserve's recent meeting minutes indicate a cautious yet optimistic approach, suggesting that while inflationary pressures are being monitored, the overall economic outlook remains positive. This balanced stance bodes well for investors seeking growth in the coming year.
Janux Therapeutics Inc. (NASDAQ: JANX)
Janux Therapeutics is a clinical-stage biopharmaceutical company specializing in the development of novel immunotherapies for cancer treatment. Leveraging its proprietary Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms, Janux aims to create therapies that are both effective and safe. In the third quarter of 2024, the company reported financial results highlighting its ongoing commitment to advancing its pipeline, with significant investments in research and development.
LandBridge Company LLC (NYSE: LB)
LandBridge is a landowner in the oil-rich Permian Basin, focusing on leasing its extensive acreage to oil and natural gas producers. Since its IPO in mid-2024, where shares debuted at $19 each, the company has demonstrated robust revenue growth. In the third quarter of 2024, LandBridge reported a 60% year-over-year increase in revenues, reaching $28.5 million. This growth underscores the company's strategic positioning and the strong demand for its assets.
Ryde Group Limited (NYSE: RYDE)
Ryde Group is a transportation and mobility services provider, offering a range of solutions from ride-sharing to electric scooter rentals. In Singapore, the recent surge in Certificate of Entitlement (COE) prices has significantly increased the cost of car ownership, pushing consumers toward more affordable e-mobility options. Ryde, as a niche player in this industry, stands to benefit from this shift. Additionally, the company's current low valuation provides a safety net for investors, making it an attractive prospect in the evolving mobility landscape.
In conclusion, the U.S. stock market in 2025 appears poised for continued growth, supported by a stable economic environment and strategic corporate advancements. Investors should consider companies like Janux Therapeutics, LandBridge Company, and Ryde Group, each offering unique value propositions in their respective sectors.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. Investors should conduct their own research or consult with a financial advisor before making investment decisions.
LB
THE WEEK AHEAD: LB, ARMK, TGT EARNINGS; XOP, GDXJ, KRE, IWM/RUTEARNINGS-RELATED VOLATILITY CONTRACTION PLAYS:
LB (7/69/16.0%):* Announcing Wednesday after market close.
ARMK (11/56/13.1%): Announcing Tuesday before market open.
TGT (30/39/8.6%): Announcing Wednesday before market open.
Honorable Mentions:
LOW (23/39/8.6%): Announcing Wednesday before market open.
HD (17/31/6.7%): Announcing Tuesday before market open.
WMT (24/30/6.4%): Announcing Tuesday before market open.
Pictured here is an LB December 18th (34 days) 29/39 short strangle paying 1.99 at the mid price as of Friday close (.99 at 50% max) with 2 x expected move break evens.
EXCHANGE-TRADED FUNDS RANKED BY BANK FOR YOUR BUCK:
XOP (14/54/12.7%)
GDXJ (15/46/11.3%)
KRE (26/45/10.6%)
USO (6/50/10.3%)
BROAD MARKET RANKED BY BUCK BANG:
IWM (25/31/6.9%)
QQQ (23/29/6.3%)
SPY (16/23/4.9%)
EFA (17/20/4.6%)
* -- The first number is the implied volatility rank or percentile (i.e., where 30-day implied volatility is relative to where it's been over the past 52 weeks); the second, 30-day implied volatility; and the third, the percentage the December at-the-money short straddle is paying as a function of stock price.
I HATE when this happens...Still Green Though - 06/02/20 RECAPHi traders,
I only did 1 trade today and was a little bummed seeing trades I passed on as being too risky work, but that's part of the game! Ending with a nice positive number and sticking to the plan. LB eventually went far beyond my TP, but it was showing weakness at one point so I played it safe.
Trades:
1) LB - LONG @17.67, +1.1%
*In my ID trades, I risk 1% of the account per trade and go for 2% (2:1 RRR ). Sometimes I adapt a little bit as you can see in the trades' description.*
Total PnL for the day: +1.1%
Total PnL for the week: +4.67%
Good trades,
Tom | FINEIGHT
A trading idea for LB.Could this pattern trigger a new rally in LB? There’s a real probability that yes, it could. Let’s see.
Today LB made a harami near previous bottom. It would be perfect if the price closed above the purple trendline, but that unfortunately didn’t happen.
Look at the volume, it increased a lot in the last two days.
If tomorrow LB closes above the harami and above the trendline, it would be a nice trade, with a nice risk/gain relationship. The target would be the black trendline, which is a very long one, dating back to 2015, so it is a quite important one.
Let’s see how that will turn out.
Will it break the range?long down trend hit long time support / resistance line at 16 ish all the way back to 1986
Range since sep 19 and its been down 4 times , without breaking it,
high volume on buyers the last few days
Made golden cross with the 20/50 MA on the daily cart
the RSI are positive and been a uptrend since sep.
I need it to break up over the small resistance at 19 ish - then i see a buy signal, befor that , it can still drop to support at 16 ish
the fundemental analyse is a littel tricky, but its still better then 2018
link : lb.gcs-web.com
Some experts was neutral befor the eanings as released but now they say buy and they are thinking 21-25 usd.
order set to : 19,5 usd
TP set to : 25
SL set to : 16
please do comment if you have something to say :)
$LB Is A Speculative BuyIt's hard to get overly bullish on $LB, but the chart has piqued our interest. The stock has very strong support at the $16 level and $LB looks to be on the verge of breaking out. With so many bearish on retail names, $LB could outperform quite easily with so many pessimists and shorts in the stock. With 8% of the float short, we could see a nice short covering rally.
$LB is also a deep value play. $LB trades at just 7.9x this year's earnings, .037x sales, and 12.12x FCF. With the stock down from 52-week highs near $30, there's a lot of room $LB can run.
While we wouldn't bet the farm on $LB, it looks to be a speculative buy at current levels.
As always, use protective stops and trade with caution.
Good luck to all!
RY (RBC BANK) | Watch For Rejection and New DowntrendRY has filled a gap created back at the beginning of 2018 and we also see a potential large double top formation on the daily and weekly timeframes that is being formed by rejection. This is an opportunity to position short for a new downtrend on the lower timeframes, looking for support on the 8/1 Gann and as low as the 4/1 Gann.
On the larger timeframe, don't forget Steve's trade (targets are my own though):
PS. Some Index funds might be worth shorting as well.
Steve Eisman's Canada TradeSteve Eisman (depicted as Marc Baum in The Big Short movie) has publicly revealed the institutions he is shorting in anticipation of the next wave of credit normalization. They include RBC, CIBC, Home Capital Group, and Laurentian Bank. Steve has not revealed his targets or how far exactly the trade will go, so the estimates on the chart are my own.
As you know, I have been establishing net short positions on numerous banks around the world since the end of last year.
LB StrangleThis is a very good example of when to do a strangle. The market is about to choose which direction to go in soon. You have NFP tomorrow, earnings for LB in 2 weeks, and a rate hike decision coming up. This is the perfect cocktail to take advantage of a big move. LB is down 11.7% today and could potentially continue down further. I have no idea which way LB will go, but I expect to make a profit on my 75 strike call 70 strike put strangle setup. I bought this setup 45 days to expiry and only paid a net debit of 4.00. You should see a nice move soon.
Cheers